期刊论文详细信息
NEUROBIOLOGY OF AGING 卷:33
Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome
Article
Coppus, Antonia M. W.1,2  Schuur, Maaike3  Oostra, Ben A.4  Verbeek, Marcel M.5,6 
[1] Erasmus MC Univ Med Ctr, Genet Epidemiol Unit, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands
[2] Ctr Intellectually Disabled, Gennep, Netherlands
[3] Erasmus MC Univ Med Ctr, Dept Neurol, NL-3000 CA Rotterdam, Netherlands
[4] Erasmus MC Univ Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands
[5] Radboud Univ Nijmegen, Alzheimer Ctr, Donders Inst Brain Cognit & Behaviour, Dept Neurol, NL-6525 ED Nijmegen, Netherlands
[6] Radboud Univ Nijmegen, Alzheimer Ctr, Donders Inst Brain Cognit & Behaviour, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands
关键词: Down syndrome;    Amyloid precursor protein;    Abeta;    Alzheimer's disease;   
DOI  :  10.1016/j.neurobiolaging.2011.08.007
来源: Elsevier
PDF
【 摘 要 】

Extracellular deposition of amyloid beta peptide (A beta) has been implicated as a critical step in the pathogenesis of Alzheimer's disease (AD). In Down syndrome (DS), Alzheimer's disease is assumed to be caused by the triplication and overexpression of the gene for amyloid precursor protein (APP), located on chromosome 21. Plasma concentrations of A beta 1-40 and A beta 1-42 were determined in a population based study of 506 persons with DS, who were screened annually for dementia. We used Cox proportional hazards models to determine the risk of dementia. Demented persons with DS have a significantly higher plasma A beta 1-40 concentration than the nondemented (p = 0.05). Those with the highest concentrations of A beta 1-40 and A beta 1-42 have a higher risk to develop dementia. The risk to develop dementia during follow-up (mean 4.7 years) increased to 2.56 (95% confidence interval, 1.39-4.71) for A beta 1-42 and 2.16 (95% confidence interval, 1.14-4.10) for A beta 1-40. High plasma concentration of plasma A beta 1-40 and A beta 1-42 are determinants of the risk of dementia in persons with DS. (C) 2012 Elsevier Inc. All rights reserved.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_neurobiolaging_2011_08_007.pdf 475KB PDF download
  文献评价指标  
  下载次数:0次 浏览次数:0次